Catawba Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | $6.83M | Buy |
198,358
+1,947
| +1% | +$67K | 1.61% | 12 |
|
|
2018
Q1 | $6.61M | Sell |
196,411
-4,810
| -2% | -$162K | 1.59% | 14 |
|
|
2017
Q4 | $6.92M | Sell |
201,221
-11,449
| -5% | -$393K | 1.56% | 17 |
|
|
2017
Q3 | $7.2M | Sell |
212,670
-1,334
| -0.6% | -$45.2K | 1.63% | 14 |
|
|
2017
Q2 | $6.82M | Buy |
214,004
+6,993
| +3% | +$223K | 1.55% | 12 |
|
|
2017
Q1 | $6.72M | Buy |
207,011
+2,165
| +1% | +$70.3K | 1.47% | 11 |
|
|
2016
Q4 | $6.31M | Sell |
204,846
-1,581
| -0.8% | -$48.7K | 1.48% | 12 |
|
|
2016
Q3 | $6.63M | Sell |
206,427
-3,715
| -2% | -$119K | 1.57% | 10 |
|
|
2016
Q2 | $7.02M | Buy |
210,142
+1,582
| +0.8% | +$52.8K | 1.7% | 8 |
|
|
2016
Q1 | $5.87M | Buy |
208,560
+555
| +0.3% | +$15.6K | 1.49% | 12 |
|
|
2015
Q4 | $6.37M | Sell |
208,005
-2,840
| -1% | -$87K | 1.73% | 8 |
|
|
2015
Q3 | $6.28M | Sell |
210,845
-13,319
| -6% | -$397K | 1.72% | 9 |
|
|
2015
Q2 | $7.13M | Sell |
224,164
-2,404
| -1% | -$76.5K | 1.7% | 9 |
|
|
2015
Q1 | $7.48M | Buy |
226,568
+208
| +0.1% | +$6.87K | 1.72% | 8 |
|
|
2014
Q4 | $6.69M | Sell |
226,360
-701
| -0.3% | -$20.7K | 1.54% | 10 |
|
|
2014
Q3 | $6.37M | Sell |
227,061
-8,904
| -4% | -$250K | 1.48% | 10 |
|
|
2014
Q2 | $6.65M | Sell |
235,965
-4,229
| -2% | -$119K | 1.49% | 8 |
|
|
2014
Q1 | $7.32M | Sell |
240,194
-3,794
| -2% | -$116K | 1.75% | 5 |
|
|
2013
Q4 | $7.09M | Sell |
243,988
-529
| -0.2% | -$15.4K | 1.7% | 5 |
|
|
2013
Q3 | $6.66M | Sell |
244,517
-270
| -0.1% | -$7.36K | 1.75% | 6 |
|
|
2013
Q2 | $6.51M | Buy |
+244,787
| New | +$6.51M | 1.81% | 6 |
|